We use cookies to improve your experience on this site. By viewing our pages, you give us consent to use cookies. Find out more.

Don’t invest unless you’re prepared to lose all the money you invest. NextFin promotes high - risk investments and you are unlikely to be protected if something goes wrong.
Take 2 minutes to learn more.

Equity Crowdfunding Pitches

Showing results
Carocell Bio is innovating by developing patented anti-inflammatory peptides delivered via nanoparticles to address severe inflammatory conditions such as atopic dermatitis. Their primary peptide, JEL0305, not only halts inflammation but also prevents its initiation, as evidenced by its effectiveness in reducing inflammation in human AD biopsies and burn tissue. With AD impacting a substantial population and costing $21 billion yearly for unsafe treatments, Carocell Bio's safer peptide remedy has the potential to avert AD recurrence. Additionally, their pioneering approach to skin-related inflammation involves topical peptide products that target mitogen-activated protein kinase (MAPK), a crucial element in inflammation. This breakthrough offers promise for managing and forestalling AD and mitigating skin aging.
days to go: Extended investment: Withheld
Optimise BP, the debut product by Optimise Health, introduces an innovative digital solution that offers secure and efficient semi-automated blood pressure management within primary care, focusing on hypertension. This advancement is projected to lead to substantial appointment savings in the range of millions.
days to go: TBC investment: £127,001
PULMOBIOMED is addressing the failings of current lung tests, which are expensive, infrequent, and invasive. Their so-called "clinically proven" solution claims to offer non-invasive liquid samples from deep within the lung, promising affordable tests for lung diseases. They assert that their product can empower clinicians to diagnose and treat conditions like lung cancer and infections, even though there's limited evidence to support these claims. With a few customers in the USA and Australia, and vague partnerships in the EU, PULMOBIOMED hopes to disrupt the asthma diagnostics market by introducing what they call a comprehensive diagnostic test for asthma, despite the skepticism around their capabilities.
days to go: Extended investment: £295,000
Stroli – the shopping trolley reimagined for modern needs. The shopping trolley, often associated with a particular image, is an untapped category ready for innovation. The market is flooded with generic, budget-friendly options that lack charm, with the exception of Rolser, which is pricier and claims the green niche. Stroli steps in as the go-to brand, offering a unique approach, positioning, voice, and eco-friendly credentials. Say goodbye to sore hands and plastic bags – Stroli makes shopping a pleasure with its high-quality, stylish trolley bags designed to enhance your convenience and style
days to go: Extended investment: Withheld
PCL Health is a Business-to-Business (B2B) Software-as-a-Service (SaaS) entity that aims to bring hospital-level care to anyone remotely. It asserts that the correct use of remote monitoring can reduce mortality by up to 45%. PCL Health intends to become a contender in the remote healthcare market that is set to touch $30 billion by 2023. It has developed CE rated medical-grade devices that use health algorithms combined with sensors and its proprietary range of apps to allow family members to proactively monitor the health of their loved ones, alongside carers and doctors, remotely. PCL Health has completed two pilots with 65 people and received a Letter Of Intent (LOI) from a National Health Service (NHS) Trust for a clinical trial. It won the 'Innovative Startup' competition at the 2019 Healthcare Unblocked event. PCL Health will use the investment for technology enhancement, running further pilot studies, and working capital.

Pitch Rated

51%

Insufficient Data

rating powered by

CROWD RATING™

days to go: Expired investment: £394,680
Swift Social is an easy-to-use social media promotional tool for creatives and SMEs. It helps everyone, no matter their experience or skill set to grow an engaged audience on social media. Since launching their beta they have gained over 800 users across 69 countries.  
days to go: Expired investment: £39,310
Assetz Exchange (AE) is a property crowdfunding platform that endeavours to break down barriers to investing in sustainable and under-supplied Buy-To-Let sectors so that investors can create a diversified property portfolio in minutes. AE argues that Buy-To-Let has hurdles, such as capital requirements, administration burden and transaction costs making it the least preferred option for average investors. It aims to change this scenario by converting properties into micro-units, allowing investors to invest as little or as much as they like, and taking care of administrative expenses. AE has launched 12 properties so far in 2020. It also concluded the purchase of four flats in a period conversion near Sefton Park in Liverpool in January 2020 for £600,000, with a plan to sell them on for £800,000. AE envisions to originate over £20 million worth of new properties in 2021. It will use the investment to expand its network of sourcing agents, build a larger credit team, invest in marketing campaigns, and increase automation wherever possible.
days to go: Expired investment: £293,382
The Juggling King (TJK) is one of the UK's first Seed-to-Bottle rum production companies from Guernsey. TJK argues that its product is the first rum ever to be distilled with cultivated sugarcane grown under glass in Guernsey and to be produced on the island. The company has appointed English former footballer Michael Owens as its global brand ambassador and featured on James Martin's Saturday Morning show. TJK has also onboarded 18 trade customers including hotels, restaurants and bars since its launch in August 2020. It will use the investment for working capital, customs & excise duty expenses, input costs, and other verticals.
days to go: Expired investment: £402,059
The go-to platform for people planning the most important purchase of their lives: a new home.
days to go: Expired investment: £103,008
HireGo is the world's first P2P car sharing application built on blockchain technology. It provides a decentralised car hiring platform for individual car owners and businesses. HireGo makes use of existing blockchain-based identity management tools to ensure that any user you interact with has been thoroughly assessed and vetted. User-review system is the key feature of HireGo. HireGo aims to reinvent and upgrade the multi-billion dollar vehicle sharing industry. So far, it has attracted a large social media following of 10K Telegram members and 11K Twitter followers. It has also been featured in media websites including TechBullion and CryptoNews.
days to go: Expired investment: £59,150
  • Internet Business Awards Category Award Winner 2015
  • Hertfordshire Business Awards Finalist 2014

As seen in:

  • The Guardian
  • Financial Times
  • Yahoo! Finance
  • The Times
  • The Daily Telegraph